Search results for Clinical trials
Page 9 of 43
-
Journal of Alzheimer's & Dementia
In silico Identification of novel ApoE4 inhibitor for Alzheimers disease therapy
Author(s): Muhammad Asif Rasheed
-
Annals of Clinical and Laboratory Research
Impact of Fingolimod on Multiple Sclerosis
Author(s): Mamatha Dereddy*
-
Archivos de Medicina
Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies
Author(s): Aseel Bin Sawad and Fatema Turkistani
-
Journal of Nephrology and Transplantation
Anticoagulation in chronic kidney disease patients: The practical aspects
Author(s): Sameh Mohamed Abouzeid
-
Annals of Clinical and Laboratory Research
Short Communication on Clinical Trials of the Drug
Author(s): Lalitha Padala*
-
Chemical Informatics
Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
Author(s): Fulmer Shealy V.K
-
Journal of Pharmacy and Pharmaceutical Research
Scientific Evidence Supporting Benefits of Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015â??2017
Author(s): US Food and Drug Administration (FDA) exercises flexibility in the requirement that new drugs provide substantial evidence of benefit under the Food, Drug and Cosmetic Act. Provisions in law and policy provide numerous exceptions to the historical scientific standard of 2 or more controlled clinical trials demonstrating statistically significant evidence of benefit.